Stribild: new once-daily single-tablet regimen for HIVDrug is the first marketed HIV combination product to contain an integrase inhibitor (elvitegravir) and a new pharmacokinetic enhancer (cobicistat). New Canadian stats on HIV/AIDS incidence and prevalenceNew treatments improved survival, boosting the number of people living with HIV. Mind-control parasite strikes again Evidence builds that T. gondii is linked with suicide ONLINE EXCLUSIVE: CAP management Optimizing care in patients with community-acquired pneumonia. Updated Canadian travel health website Site touted as a “one-stop shop” for obtaining information on international travel. Probiotic use reduces C. difficile-associated diarrhea Occurrence of Clostridium difficile-associated diarrhea can be significantly, safely reduced by taking probiotics, new study finds. Practice Issues: Medication Forum Advice for healthcare providers after distribution suspended for two Novartis flu vaccines Several European countries have already withdrawn the two vaccines from use after white floating particles and clumping were seen in a few lots of the vaccines in Italy Researchers ferret out the truth about troubling H1N1 finding Controversial observation confirmed in animal studies Treatment reduces transmission of drug-resistant HIV Better therapy linked with fewer viral mutations in Quebec study First Previous 109 110 111 112 113 Next Last
